Search

everythinglearnresearchcommunity

for

Search:↓

The model can effectively test gene functions and drug responses in human skin.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

Astrotactin2 affects hair follicle orientation and skin cell polarity.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Using a stimulating cream shampoo before applying Minoxidil helps it penetrate hair follicles better, enhancing its hair growth-promoting effect.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Activating TLR3 helps improve skin and hair follicle regeneration after wounds.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

The issue concluded that various skin conditions have different effective treatments and factors influencing them.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Minoxidil ingestion can raise liver enzyme levels.

Nebivolol cream may be a promising hair loss treatment by improving blood flow and nourishing hair follicles.

The enzymes Tet1, Tet2, and Tet3 are important for the development of hair follicles and determining hair shape by controlling hair keratin genes.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.